Superworth

Angiodynamics price to free cash flow ANGO

Market value divided by free cash flow over the last twelve months, since 2012.

Today, Nov 2, 2026
342×
10-year median
21.7×
Against its 10-year history
98th
percentile: 0 is its lowest day, 100 its highest
10-year range
10.6× to 368×
Peer median
12.3×

Angiodynamics' price to free cash flow is 342× as of Nov 2, 2026.

That is above its ten-year median of 21.7×, higher than on 98% of days in the last ten years.

Over that time it ranged from 10.6× in Apr 2017 to 368× in Jun 2026.

The median for 10 medical instruments and supplies stocks of a similar size is 12.3×.

Price to free cash flow over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far342×269×368×
2025n/m a value too high to mean anything
2024n/m a value too high to mean anything
2023n/m a value too high to mean anything
2022125×115×134×
202165.7×49.2×110×
202013.4×12.0×21.5×
201916.7×14.9×29.8×
201827.9×13.4×30.1×
201712.6×10.6×13.4×
201613.6×11.7×21.9×
201524.5×22.9×73.2×
201473.0×23.7×73.0×
201322.9×19.8×86.2×
201240.4×40.0×48.4×

Against its peers

Companies in Medical - Instruments & Supplies nearest Angiodynamics' size, closest first, today.

CompanyPrice to free cash flow
ANGOAngiodynamics342×
TCMDTactile Systems Technology19.3×
EMBCEmbecta2.1×
MOVMovado10.0×
INFUInfuSystem12.0×
IRMDIradimed38.9×
IARTIntegra Lifesciences12.3×
UTMDUtah Medical Products19.6×
BVSBioventus11.7×
STAAStaar Surgicaln/m
PDEXPro DEX17.3×
Peer median12.3×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Angiodynamics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.